Exploring the potential molecular mechanism of JinlingziSan in the treatment of endometriosis based on network pharmacology system

In: Drug Combination Therapy · 2023 · vol. 5(2) , pp. 8 · doi:10.53388/dct20230008 · W4375825129
article OA: hybrid CC0
AI-generated summary by claude@2026-06, 2026-06-07

This study used network pharmacology to investigate how JinlingziSan might treat endometriosis by identifying its potential molecular targets and pathways.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK